CLRB - Cellectar Biosciences Inc
IEX Last Trade
2.2
0.010 0.455%
Share volume: 178,927
Last Updated: Fri 30 Aug 2024 09:57:27 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.19
0.01
0.46%
Summary score
22%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.48%
Return on assets
-26.39%
Return on sales
0%
Return on invested capital
570.91%
Total debt ratio
19.64%
Debt ratio change over timeo
-0.99%
Current Ratio
5.37%
Quick Ratio
0%
Cash Position Ratio
4.97%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.68%
Return on assets
-28.42%
Return on sales
0%
Return on invested capital
171.93%
Total debt ratio
25.95%
Debt ratio change over timeo
-0.86%
Current Ratio
4.65%
Quick Ratio
0%
Cash Position Ratio
4.35%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.07%
Return on assets
-15.19%
Return on sales
0%
Return on invested capital
143.84%
Total debt ratio
16.21%
Debt ratio change over time
-0.91%
Current Ratio
6.94%
Quick Ratio
0%
Cash Position Ratio
6.76%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-99.93%
Return on assets
-99.08%
Return on sales
0%
Return on invested capital
-63.91%
Total debt ratio
-99.19%
Debt ratio change over time
-0.99%
Current Ratio
-1.47%
Quick Ratio
0%
Cash Position Ratio
-1.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLRB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -36.48% | -3.05% | 11.55% | 6.27% |
| Return on assets | -26.39% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 570.91% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 19.64% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.99% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 4.65% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.35% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 21% | 45% | 46% |
| Short-term ratios | CLRB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -40.68% | -25.62% | 17.94% | 7.14% |
| Return on assets | -28.42% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 171.93% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 71% | 60% |
| Total debt ratio | 25.95% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.86% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 4.65% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.35% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 37% | 30% | 52% |